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Abstract 
 
Background: Ischemia-induced brain damage is the leading cause of adult disability and the fifth leading 
cause of death, and thus, the development of anti-apoptotic neuro-protective therapeutic agents is viewed as 
an attractive developmental strategy. Glycyrrhizin is the main sweet component in licorice and has a number 
of pharmacological activities, which include neuro-protective, anti-fungal, and anti-cariogenic activities. 
This study was undertaken to investigate the effects of glycyrrhizin on ischemia-induced brain damage. 
Materials and Methods: In infarct volumes and the levels of several apoptosis-related proteins, caspase-3, -
8, 9, Bcl-xL, Bcl-2,and their activities in the brains of middle cerebral artery occlusion (MCAO) treated mice 
were measured using western blotting methods.  
Results: Single pre-treatment with glycyrrhizin (10-100 mg/kg)at 2 hours before MCAO significantly 
reduced infarct volumes at 24h after MCAO. In addition, glycyrrhizin effectively inhibited the activations of 
caspase-3 and -9 and the down-regulation of Bcl-xLprotein caused by MCAO.  
Conclusion: The neuro-protective effect of glycyrrhizin was found to be due to its regulation of apoptosis-
related proteins signals.The authors suggest glycyrrhizin be considered a potential candidate for the 
treatment of ischemia induced brain damage. 
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Introduction 
 
Glycyrrhizin (glycyrrhizic acid) is one of main constituents of Glycyrrhiza glabra or G. 
uralensis (licorice) roots, and has been shown to have a number of pharmacological activities, which 
including neuro-protective(Kim et al., 2011; 2012; Luo et al., 2013), anti-fungal(Guo, 1991), and anti-
cariogeniceffects (Segal et al., 1985). Isoliquiritigenin, a natural phenol isolated from licorice, has been 
reported to have protective effects on transient MCAO induced focal cerebral ischemia in rats(Zhan and 
Yang, 2006). In total, 122 compounds have been isolated from G. uralensis and extensively tested using 
various bioassay methods(Ji et al., 2016; Ota et al., 2015; Yang et al., 2015b; Zhu et al., 2016).Kumagai et 
al.(1957) reported glycyrrhizincompetitively inhibits the metabolism of corticosteroidsand that it has a 
corticosteroid-like effect (Kumagai et al., 1957). 
Corticosteroidsare often administered by clinicians, butevidence concerning their effects on acute 
cerebral infarction is lacking. However, corticosteroids are believed to reduce cytotoxic and vasogenic brain 
edema when administered to ischemic cerebral stroke (Faraji et al., 2009; Feigin et al., 2005; Sandercock and 
Soane, 2011).  
Stroke is a leading cause of adult death and permanent disability, and ischemic strokeaccounts for 
around 80% of strokes (Poisson et al., 2014).Furthermore, the incidence of stroke is increasing among young 
adults(Bejot et al., 2016).  
Ischemia/reperfusion-induced stroke can be characterized by focal loss of brain blood circulation, 
and often leads to neuronal injury or death (Hadadha et al., 2015; Zhao et al., 2015).Kim et al.(2012) 
concluded that the anti-inflammatory and anti-oxidative effects of glycyrrhizin were responsible for its 
neuroprotective effect post-ischemia in a rat MCAO model (Kim et al., 2012). However, the effects of 
glycyrrhizinhave not been determined in a mouse MCAO model of ischemia. Thus, in the present study, we 
sought to determine whether glycyrrhizinprotects against ischemia/reperfusion induced brain damage and to 
identify the mechanism responsible in a mouse MCAO model. 
 
Materials and Methods 
Glycyrrhizin treatment 
 
Glycyrrhizin was purchased from Sigma-Aldrich (Millipore Sigma, MO, USA), dissolved in 
dimethyl sulfoxide (DMSO) to concentration of 100 mg/ml, and then again diluted with tap water to 
concentration of 2 mg/ml. 
 
Animal model 
 
The animal experiment protocol was approved by the ethics committee of our institution (approval 
number, PNU-2016-1087). Male SPF C57BL/6 mice (DaehanBiolink, Chungbuk, Korea) (22-25 g) were 
housed in a humidity and temperature controlled environment under a 12h light cycle, and provided food and 
water ad libitum. For the experiment animals were randomly divided into five groups, namely, the sham 
control group (members of which underwent surgery but not MCAO), the non-glycyrrhizin treated MCAO 
group (the MCAO control group), and the 10, 30, or 100 mg/kg glycyrrhizin treated groups (the 10, 30, and 
100 mg/kg groups)each group consisted of at least 15animals. 
Before MCAO, mice in glycyrrhizin treatment groups were orally administered 10, 30, or 100 
mg/kg of body weight 1 hr before commencing the MCAO procedure (Fig. 1(A)). MCAO was conducted 
under 2% isoflurane anesthesia. During surgery, rectal temperature was maintained at 37±0.5°C with a 
heating pad, andrelative cerebral blood flow (rCBF) was monitored using a laser Doppler blood flow system 
(moorVMS-LDF, Moor Instruments, Devon, UK). Briefly, under a stereo microscope (Nikon745, Tokyo), 
the left external carotid artery and the left common carotid artery were bound with 4/0 silk sutures (Ethicon 
Inc., NJ, USA).Theleft middle cerebral artery was then occluded using a filament (11 mm length of 8/0 
nylon suture with a silicon-coated tip), and after 2h of occlusion, the filament was withdrawn. The success of 
the procedure was confirmed by a reduction in rCBF of >80% during the 2h ischemic period, and a sharp 
increase in rCBF to >90% of baseline during reperfusion. Surgical procedures performed in an identical 
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manner in the sham group but the left middle cerebral artery was not occluded.Mice were anesthetized and 
sacrificed24 hrafter commencing MCAO. 
 
 
 
Figure 1: Design of the MCAO model and representative group images. (A) Glycyrrhizin was pre-treated 1 
hr before commencing MCAO, and mice were sacrificed 24 hr after commencing MCAO (24h post-
MCAO). Harvested brain slices were kept in deep freezer for protein assays, or stained with TTCto measure 
infarct volumes. (B) Ischemic regions were identified as pale regions in coronal slices.  
 
Measurement of infarct volumes 
 
Brains harvested at 24h post-MCAO were immediately sectioned at 1 mm coronal sections to 
obtain 10 sections/brain. Sections were then incubated with 2% 2,3,5-triphenyl-tetrazolium chloride (TTC) 
solution for 17 min at 25°C and fixed in 10% neutral buffered formalin for more than 2 hr. Digital images 
were obtained using a digital camera, and infarct and relative edema volumes were calculated using Image J 
software (NIH, Maryland, USA). 
 
Neurological deficit scores 
 
Neurological deficit scores were assessed at 24 hrpost-MCAOusing a five-point scale. Briefly, the 
scores were calculated as follows: 0, no neurological deficit; 1, failure to extend right forepawand a reduced 
grip; 2, spontaneous movement in all directions and circling to the rightwhen the tail was pulled; 3, circling 
or walking to the rightwhen stimulated; 4, unresponsive to stimulation or stroke-related death.  
 
Western blot analysis 
 
Ipsi-lateral brain tissues including hippocampus and cortex were extracted and homogenized in 
tissue lysis buffer. Proteins were separated by 10% sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE), and then transferred to nitrocellulose membranes (Whatman, Maidstone, 
UK).Membranes were blocked using 5% skim milk in TBST buffer for 1 hr at room temperature and then 
incubated overnight at 4°C with specific antibodies for caspase-3, -8, 9, Bcl-xL, Bcl-2 (1:1000), and β-actin 
(1:2000) for internal control. Antibodies listed above were purchased from Cell Signaling Technology 
(Danvers, MA, USA). After overnight incubation, horse radish peroxidase (HRP) conjugated goat anti-rabbit 
IgG, pAb (1:5000) and HRP conjugated goat anti-mouse IgG pAb (1:3000) were added for 2 hours. 
Membranes were then treated with ECL solution (GenDEPOT, Houston, TX, USA) and protein bands were 
detected using a photosensitive luminescent analyzer system (Amersham™ Imager 600, UK). Relative  
116 
 
protein amounts were analyzedusing the Image J program (NIH, Maryland, USA) versus β-actin. 
 
Statistical analysis 
 
One-way ANOVA was used to determine the statistical significance of differences. Data are 
expressed as means±standard deviations (means ±SD). SIGMAPLOT 12.0 version was used to statistical 
analysis, and p-values of ≤0.05 were considered statistically significant. 
 
Results 
Effects of glycyrrhizin on behavioral deficits and infarct volumes 
 
At 24h post-MCAO, motor behavioral deficit scores were significantly higher in mice subjected to 
MCAO.Glycyrrhizin pre-treatment exhibited no significant reduction in neuronal deficit scores versus the 
MCAO control group (Figure 2(A)). Regions of ischemic infarction were confirmed by TTC staining, and 
MCAO was found to induce severe damage in ipsilateral hemispheres. However, mice pre-treated with 
glycyrrhizin (10, 30, or 100 mg/kg) had significantly smaller infarct lesions than MCAO controls 
(Figure 2(B)). 
 
 
 
 
Figure 2: Effects of glycyrrhizinon neurological deficit scores and infarct volumes.Glycyrrhizin pre-
treatment did not improve neuronal deficit scores (A), but significantly decreasedinfarct volumes at 24h 
post-MCAO (B). Results are presented as means ± SDs.###p<0.001 vs. Sham controls, *p<0.05, **p<0.01 vs. 
MCAO controls; n=8 in (A), n=6 in (B).  
 
Effects of glycyrrhizin on the expressions of apoptosis related proteins  
 
In ipsilateral hemispheres of MCAO subjected brains, western blot analysis at 24-post MCAO 
revealed Bcl-xLlevels were significantly lower than in sham controls (Figure 3). However, mice in the 10, 
30, and 100 mg/kg groups hadsignificant higher Bcl-xLlevels than mice in the sham control group (Figure 3).  
Glycyrrhizin pre-treatment down-regulated caspase-3 and caspase-9 in ischemic brains, but caspase-8 levels 
were similar in all five study groups (Figure 4). 
Western blot analysis at 24h-post MCAO revealed Bcl-2 expression was significantly lower in all 
MCAO groups than in sham controls (Figure 5).  
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Figure 3: Effects of glycyrrhizin on Bcl-xLlevelsin the brains of MCAO-induced mice. Western blotting 
showedglycyrrhizin blocked the down-regulation of Bcl-xLby MCAO. Results are presented as means ± 
SDs. ###p<0.001 vs. Sham controls, **p<0.01 vs. MCAO controls; n=5.  
 
 
Figure 4: Effects of glycyrrhizin on brain caspase levels. Caspase-3, -8, and -9 were assessed by Western 
blotting.Glycyrrhizinwas found to block the MCAO-induced up-regulations of caspase-3 and -9. Results are 
presented as means ± SDs. ###p<0.001 vs. Sham controls, **p<0.01, ***p<0.001 vs. MCAO controls; n=5.  
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Figure 5: Effects of glycyrrhizin on brain Bcl-2 levels. Western blotting showed Bcl-2 levels were 
suppressed by MCAO and that glycyrrhizinhad no effect on this suppression. Results are presented as means 
± SDs. ###p<0.001 vs. Sham controls; n=5. 
 
Discussion and Conclusion 
 
Ischemia-induced brain damage, also called “stroke” or “brain attack”, is associated with oxidative 
stress and neuro-inflammation,in turn, cause diverse motor and speechdisorders (Chamorro et al., 2016; Roth 
andLiesz, 2016). A stroke can occur at any time, and in the USA, nearly 800,000 people experience a new or 
recurrent stroke annually.Stroke is the leading cause of adult disability and the fifth-most leading cause of 
death(Bejotet al., 2016; Hachinski andAzarpazhooh, 2016; Poisson et al., 2014). The severities of motor and 
speech disordersdepend on the extent of brain damage(Barlow, 2016), and thus, anti-apoptotic neuro-
protective therapeutic agents offer an attractive developmental strategy.  
In a preliminary study, we observed oral glycyrrhizin reducedbrain infarct volumes in MCAO-
treated mice, and in the present study, single doses of glycyrrhizinof from 10 to 100 mg/kg produced similar 
results (Figures 1 and 2). In order to identify beneficial effects of glycyrrhizin, we assessed the levels of 
several apoptosis-related proteins and their activities in ipsilateral brains.  
Caspases are classified based on the roles they play during apoptosis.Caspases-8 and -9 are called 
“initiator caspases”, because they activate executioner caspases (caspases -3, -6, and -7), which induce the 
destruction ofkey structural proteins. Caspase-3 is responsible for DNA fragmentation and plays a critical 
role in apoptosis (McIlwain et al., 2015; Sun et al., 2015). Recently, several researchers have suggested 
ischemia/reperfusion-induced brain injury might be ameliorated by inhibiting caspase-3 signaling (Wen et 
al., 2016;Yang et al., 2015a), and in the present study, glycyrrhizinwas found to inhibit increase in caspase-3 
and -9 levelscaused by MCAO-induced brain damage (Figure 4).  
The Bcl-2 and caspase families play act as regulators of the apoptotic pathway, and interestingly, 
members of this family act as positive or negative regulators. Bcl-xL is an anti-apoptotic member of the Bcl-
2 family (Dragovich et al., 1998; Wu and Tang, 2016), and in the present study, its levels, and those of Bcl-
2,  
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were significantly lower in damaged brains.Furthermore, glycyrrhizinpretreatment effectively inhibited 
reduced this MCAO-induced Bcl-xLdown-regulation (Figure 3, Figure 5).  
Our results suggest that glycyrrhizinpretreatment decreasedinfarct volumesin the brains of MCAO-
treated miceby regulating apoptosis-related protein signaling (Figure 6). Accordingly, our findings indicate 
that glycyrrhizinis a promising candidate for the prevention or treatment of ischemia-induced brain damage. 
 
 
Figure 6: Schematic of the anti-apoptotic action effect of glycyrrhizin in the MCAO mouse model. Red 
arrows indicate predicted effects of glycyrrhizin on ischemia/reperfusion induced brain damage.  
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